CUSIP No. G6855A103 13G Page 6 of 10 Pages

EXHIBIT 1

AGREEMENT

Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Ordinary Shares of Oxford Immunotec Global PLC.

Date: August 21, 2017

NEW LEAF VENTURES II, L.P.
By:	NEW LEAF VENTURE ASSOCIATES II, L.P.
	General Partner

	By:     NEW LEAF VENTURE MANAGEMENT II, L.L.C.
	General Partner
	By: /s/ Craig L. Slutzkin
	Craig L. Slutzkin
	Chief Financial Officer
NEW LEAF VENTURE ASSOCIATES II, L.P.
By:	NEW LEAF VENTURE MANAGEMENT II, L.L.C.
	General Partner
	By: /s/ Craig L. Slutzkin
	Craig L. Slutzkin
	Chief Financial Officer

NEW LEAF VENTURE MANAGEMENT II, L.L.C.
By:	/s/ Craig L. Slutzkin
	Craig L. Slutzkin
	Chief Financial Officer

            *

Vijay Lathi

            *

Ronald Hunt

            *

Jeani Delagardelle

            *

Liam Ratcliffe

CUSIP No. G6855A103 13G Page 7 of 10 Pages

*/s/ Craig L. Slutzkin

Craig L. Slutzkin

As attorney-in-fact

* This Schedule 13G was executed by Craig L. Slutzkin on behalf of the individuals listed above pursuant to Powers of Attorney, copies of which are attached as Exhibit 2.